DD222496A5 - Verfahren zur herstellung von tabletten mit ph-unabhaengiger gesteuerter freigabe - Google Patents

Verfahren zur herstellung von tabletten mit ph-unabhaengiger gesteuerter freigabe Download PDF

Info

Publication number
DD222496A5
DD222496A5 DD84261735A DD26173584A DD222496A5 DD 222496 A5 DD222496 A5 DD 222496A5 DD 84261735 A DD84261735 A DD 84261735A DD 26173584 A DD26173584 A DD 26173584A DD 222496 A5 DD222496 A5 DD 222496A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
dipyridamole
item
mass
tablets
Prior art date
Application number
DD84261735A
Other languages
German (de)
English (en)
Inventor
Jung-Yong Park
Jerzy Debski
Kieran G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of DD222496A5 publication Critical patent/DD222496A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD84261735A 1983-04-08 1984-04-06 Verfahren zur herstellung von tabletten mit ph-unabhaengiger gesteuerter freigabe DD222496A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (1)

Publication Number Publication Date
DD222496A5 true DD222496A5 (de) 1985-05-22

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84261735A DD222496A5 (de) 1983-04-08 1984-04-06 Verfahren zur herstellung von tabletten mit ph-unabhaengiger gesteuerter freigabe

Country Status (20)

Country Link
EP (1) EP0121901B1 (no)
JP (1) JPS6034906A (no)
KR (1) KR880002139B1 (no)
AT (1) ATE32980T1 (no)
AU (1) AU570446B2 (no)
CA (1) CA1219216A (no)
DD (1) DD222496A5 (no)
DE (1) DE3469848D1 (no)
DK (1) DK166259C (no)
ES (1) ES531346A0 (no)
FI (1) FI82604C (no)
GR (1) GR81907B (no)
HU (1) HU191542B (no)
IE (1) IE57220B1 (no)
IL (1) IL71458A (no)
NO (1) NO164958C (no)
NZ (1) NZ207768A (no)
PH (1) PH21585A (no)
PT (1) PT78380B (no)
ZA (1) ZA842562B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
KR20080037732A (ko) * 2005-08-22 2008-04-30 노파르티스 아게 ｐＨ-의존성 약물, ｐＨ 개질제 및 지연제를 포함하는제약학적 조성물
EP2101733B1 (en) 2006-12-13 2012-09-26 F. Hoffmann-La Roche AG Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
NO164958B (no) 1990-08-27
KR880002139B1 (ko) 1988-10-17
FI82604B (fi) 1990-12-31
JPH0521892B2 (no) 1993-03-25
AU570446B2 (en) 1988-03-17
IL71458A (en) 1987-09-16
ES8601687A1 (es) 1985-11-01
HU191542B (en) 1987-03-30
FI82604C (fi) 1991-04-10
NO841372L (no) 1984-10-09
NZ207768A (en) 1987-02-20
IE57220B1 (en) 1992-06-03
EP0121901A1 (en) 1984-10-17
DK166259C (da) 1993-08-23
DK181084D0 (da) 1984-04-06
DK181084A (da) 1984-10-09
JPS6034906A (ja) 1985-02-22
DE3469848D1 (en) 1988-04-21
ATE32980T1 (de) 1988-04-15
KR840008588A (ko) 1984-12-17
FI841369A0 (fi) 1984-04-06
GR81907B (no) 1984-12-12
IE840856L (en) 1984-10-08
PT78380B (en) 1986-08-14
ZA842562B (en) 1985-12-24
ES531346A0 (es) 1985-11-01
IL71458A0 (en) 1984-07-31
EP0121901B1 (en) 1988-03-16
CA1219216A (en) 1987-03-17
DK166259B (da) 1993-03-29
HUT34345A (en) 1985-03-28
AU2660984A (en) 1984-10-11
FI841369A (fi) 1984-10-09
PH21585A (en) 1987-12-11
PT78380A (en) 1984-05-01
NO164958C (no) 1990-12-05

Similar Documents

Publication Publication Date Title
EP0068191B2 (de) Orale Dipyridamolformen
EP0348808B1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung
DE60128215T2 (de) Beschichtungszusammensetzung zur geschmacksmaskierung
DE69732113T2 (de) Schnelllösliche tablette enthaltend galanthaminhydrobromid
DE69910183T2 (de) Darmlösliche sprudelnde zusammensetzungen
DE69825165T2 (de) Arzneimittelform mit zwei überzugs-schichten
DE2551280A1 (de) L-dopa-zubereitung
EP0682945A2 (de) Orale Retard-Präparation
DE2323686A1 (de) Arzneimittelzubereitungsform mit langzeitwirkung und verfahren zu ihrer herstellung
DE3237575A1 (de) Neue orale mopidamolformen
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
AT4327U1 (de) Pharmazeutische formulierung
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE102004011512A1 (de) Pharmazeutische Zubereitung enthaltend Pimobendan
EP1296685B1 (de) Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung
AT500135A1 (de) Organische verbindungen
DE3834794C2 (no)
DE60225686T2 (de) Paracetamol enthaltende tablette
DE10297329T5 (de) Dexibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung
DD222496A5 (de) Verfahren zur herstellung von tabletten mit ph-unabhaengiger gesteuerter freigabe
EP0146863A2 (de) Orale retardierte Acetylsalicylsäureformulierungen
DE2732335C2 (de) Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
DE69817379T2 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DE60312642T2 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee